Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia

Journal of Psychopharmacology

Volumn 20, Issue 1, 2006, Pages 75-79

  Hosojima, Hideki ^a,b   Togo, Takashi ^b,c   Odawara, Toshinari ^a,b   Hasegawa, Koichi ^b   Miura, Satoshi ^b   Kato, Yuiko ^a,b   Kanai, Akiko ^a,b   Kase, Akihiko ^c   Uchikado, Hirotake ^b   Hirayasu, Yoshio ^b  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Yokohama Maioka Hospital   (Japan)

Author keywords

Adiponectin; Diabetes; Ghrelin; Leptin; Olanzapine; Schizophrenia; Weight gain

Indexed keywords

ADIPONECTIN; GHRELIN; GLUCOSE; INSULIN; LEPTIN; NEUROLEPTIC AGENT; OLANZAPINE; BENZODIAZEPINE DERIVATIVE; PEPTIDE HORMONE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DRUG EFFECT; ENERGY BALANCE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT; STATISTICAL SIGNIFICANCE; WEIGHT GAIN; BLOOD; BODY MASS; CLINICAL TRIAL; INSULIN RESISTANCE; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADIPONECTIN; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; PEPTIDE HORMONES; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33645214469     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881105056647     Document Type: Article

References (35)

1. Allison D B, Mentore J L, Heo M, Chandler L P, Cappelleri J C, Infante M C, Weiden P J (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686-1696
2. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (Suppl. 1): S5-S10
3. Atmaca M, Kuloglu M, Tezcan E, Ustundag B (2003) Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics. J Clin Psychiatry 64: 598-604
4. Bromel T, Blum W F, Ziegler A, Schulz E, Bender M, Fleischhaker C, Remschmidt H, Krieg J C, Hebebrand J (1998) Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 3: 76-80
5. Cooper G D, Pickavance L C, Wilding J P, Halford J C, Goudie A J (2005) A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl)
6. Cummings D E, Purnell J Q, Frayo R S, Schmidova K, Wisse B E, Weigle D S (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714-1719
7. Graham K A, Perkins D O, Edwards L J, Barrier Jr R C, Lieberman J A, Harp J B (2005) Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. Am J Psychiatry 162: 118-123
8. Henderson D C, Cagliero E, Copeland P M, Borba C P, Evins E, Hayden D, Weber M T, Anderson E J, Allison D B, Daley T B, Schoenfeld D, Goff D C (2005) Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 62: 19-28
9. Herran A, Garcia-Unzueta M T, Amado J A, de La Maza M T, Alvarez C, Vazquez-Barquero J L (2001) Effects of long-term treatment with antipsychotics on serum leptin levels. Br J Psychiatry 179: 59-62
10. Janeckova R (2001) The role of leptin in human physiology and pathophysiology. Physiol Res 50: 443-459
11. Jin H, Meyer J M, Jeste D V (2002) Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann Clin Psychiatry 14: 59-64
12. Kraus T, Haack M, Schuld A, Hinze-Selch D, Kuhn M, Uhr M, Pollmacher T (1999) Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156: 312-314
13. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660
14. Lukoff D, Nuechterlein K H, Ventura J (1986) Manual for Expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bull 12: 594-602
15. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221: 286-289
16. Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C (1985) Homeostasis model assessment: insulin resistance and [beta]-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419
17. Matsumoto M, Hosoda H, Kitajima Y, Morozumi N, Minamitake Y, Tanaka S, Matsuo H, Kojima M, Hayashi Y, Kangawa K (2001) Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun 257: 142-146
18. McIntyre R S, McCann S M, Kennedy S H (2001) Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 46: 273-281
19. Melkersson K I, Dahl M L (2003) Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses. Psychopharmacology (Berl) 170(2): 157-166
20. Murashita M, Kusumi I, Inoue T, Takahashi Y, Hosoda H, Kangawa K, Koyama T (2005) Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology 30: 106-110
21. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409: 194-198
22. Newcomer J W, Haupt D W, Fucetola R, Melson A K, Schweiger J A, Cooper B P, Selke G (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 59: 337-345
23. Prolo P, Wong M L, Licinio J (1998) Leptin. Int J Biochem Cell Biol 30: 1285-1290
24. Qi Y, Takahashi N, Hileman S M, Patel H R, Berg A H, Pajvani U B, Scherer P E, Ahima R S (2004) Adiponectin acts in the brain to decrease body weight. Nat Med 10: 524-529
25. Scherer P E, Williams S, Fogliano M, Baldini G, Lodish H F (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749
26. Sernyak M J, Leslie D L, Alarcon R D, Losonczy M F, Rosenheck R (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 159: 561-566
27. Sowell M, Mukhopadhyay N, Cavazzoni P, Carlson C, Mudaliar S, Chinnapongse S, Ray A, Davis T, Breier A, Henry R R, Dananberg J (2003) Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. J Clin Endocrinol Metab 88: 5875-5880
28. Togo T, Hasegawa K, Miura S, Hosojima H, Kojima K, Shoji M, Kase A, Uchikado H, Iseki E, Kosaka K (2004a) Serum ghrelin concentrations in patients receiving olanzapine or risperidone. Psychopharmacology (Berl) 172: 230-232
29. Togo T, Kojima T, Shoji M, Kase A, Uchikado H, Katsuse O, Iseki E, Kosaka K (2004b) Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study. Int Clin Psychopharmacol 19: 37-40
30. Tschop M, Smiley D L, Heiman M L (2000) Ghrelin induces adiposity in rodents. Nature 407: 908-913
31. Tschop M, Wawarta R, Riepl R L, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C (2001) Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24: RC19-RC21
32. Wetterling T (2001) Bodyweight gain with atypical antipsychotics, A comparative review. Drug Saf 24: 59-73
33. Wren A M, Seal L J, Cohen M A, Brynes A E, Frost G S, Murphy K G, Dhillo W S, Ghatei M A, Bloom S R (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992
34. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946
35. Zigman J M, Elmquist J K (2003) Minireview: from anorexia to obesity - the yin and yang of body weight control. Endocrinology 144: 3749-3756